HomeAgenda

Jiksak Bioengineering

Company (SME/startup) / 中小企業・スタートアップ

www.jiksak.co.jp/Kawasaki, Japan
78 profile visits

About

At Jiksak—where innovation meets neuron drug delivery and nerve repair. We're a biotech company dedicated to groundbreaking therapies for neurodegenerative disorders and nerve repair. Our technologies include:

·       Drug-Linked Carrier (DLC): An advanced drug delivery system utilizing motor neuron axons to bypass the Blood-Brain Barrier (BBB) and Blood-Spinal Cord Barrier (BSCB) for drug delivery into the CNS.

Publication: Yee, KKL et al. Molecular Therapy: Methods & Clinical Development (Vol. 33, Issue 2) ; ”Harnessing synaptic vesicle release and recycling with antibody shuttle for targeted delivery of therapeutics to neurons” https://www.sciencedirect.com/science/article/pii/S2329050125000713

·       Nerve Organoids: Human iPSC-derived nerve tissues that replicate the complexity of living nerves, ideal for predictive disease modeling and drug screening. 3D axon bundles derive from these nerve organoids are also used as innovative nerve repair scaffolds composed of acellular axonal tissues embedded within a biocompatible matrix, to guide effective nerve regeneration.

Publication: Nishijima, Takayuki, et al. Inflammation and Regeneration 44.1 (2024): 6."Novel artificial nerve transplantation of human iPSC-derived neurite bundles enhanced nerve regeneration after peripheral nerve injury." https://link.springer.com/article/10.1186/s41232-024-00319-4

·       Engineered Synaptogenic Beads: Protein-coated beads designed to mimic in vivo presynaptic formation, facilitating in vitro studies and accelerating discovery of therapeutic compounds for motor neuron repair.

Join us at the forefront of neuroscience innovation—partner with Jiksak to redefine what's possible in nerve repair and neurodegenerative treatment.

Social media

Business Domain / 分野

Pharmaceuticals / 医薬品Medical devices / 医薬機器Others /その他

Business Type / 業種

R&D / 研究開発Others / その他

Modalities / モダリティ

Small-molecule drug / 低分子医薬Peptide, Protein / ペプチド、タンパクAntibody drug / 抗体医薬Oligonucleotide drug /核酸医薬Gene therapy /遺伝子治療Others /その他

Disease Area / 疾患領域

Neurology & Psychiatry / 中枢神経、精神疾患Musculoskeletal System / 筋骨格系Rare diseases / 希少疾患Others / その他

Technologies / 技術

Drug delivery system(DDS) / ドラッグデリバリーシステム(DDS)Others / その他

Additional questions

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Major pharma etc. (Out-licensing purpose) / 大手ファーマ等(アウトライセンスを目的)Startups, BioTech etc. (In-licensing or Partnership/Collaboration purpose) / 独自の技術やシーズを持つスタートアップ、バイオテック企業等(インライセンス、共同研究などを目的)Companies and Entities (Providing your services or technology to your clients) / 技術・サービス(研究、開発、製造等の提供を目的)CROs, CMOs, CDMOs, etc. (Partnerships)/CRO、CMO、CDMO等(インライセンス、共同研究などを目的)

Researched disease area / マッチングご希望の疾患領域

Neurology & Psychiatryy / 中枢神経、精神疾患Musculoskeletal System / 筋骨格系Rare diseases / 希少疾患Others /その他

Researched Modality / マッチングご希望のモダリティ

Small-molecule drug/低分子医薬Peptide, Protein / ペプチド、タンパクAntibody drug / 抗体医薬Oligonucleotide drug / 核酸医薬Gene therapy/ 遺伝子治療Others / その他

Researched Technologies / マッチングご希望の技術

Others /その他

Marketplace (5)